Navigation Links
BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
Date:7/29/2008

human tissue. Monte Carlo requires a 3D CT-scan of the patient's tissue to create an internal model of the patient and to calculate the dose distribution of the radiation emitted by a linear accelerator. The present implementation is designed to model photon radiation.

Conventional dose calculation algorithms, such as Pencil Beam, were used for cranial as well as extra-cranial indications before the application of the Monte Carlo method in the field of radiation therapy. Pencil Beam has proven effective for tumors located in homogeneous regions with similar tissue consistency such as the brain. However, these algorithms tend to overestimate the dose distribution in extra-cranial tumors such as in the lung and head & neck regions where large inhomogenities exist because of the proximity of bone, soft tissue and air cavities. Due to the inconsistencies seen in current calculation methods for extra-cranial treatments and the need for more precise radiation delivery, research has led to the creation and integration of improved calculation methods into treatment planning.

Many clinicians see the Monte Carlo Dose Calculation Algorithm as a superior algorithm for lung and head & neck treatments as compared to other computing algorithms, such as the collapsed cone or convolution methods.

The BrainLAB Monte Carlo Dose Calculation Algorithm is an integral part of the iPlan RT Dose software version 4 and provides clinicians with additional dose planning options, offering more informed treatment planning and improved clinical outcomes.

About BrainLAB

BrainLAB develops manufactures and markets software-driven medical technology that enables procedures that are more precise, less invasive, and less expensive than traditional treatments. Among the core products are image-guided systems that provide highly accurate real-time information used for navigation during surgical procedures. This utility has been further expanded to serve as a computer te
'/>"/>

SOURCE BrainLAB Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
2. Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS)
3. National Brain Tumor Foundation Unites with BrainLAB in Support of Patient Education
4. Align Technology Announces Second Quarter Fiscal 2008 Results
5. Monogram Announces 2008 Second Quarter Financial Results
6. Webcast Alert: Medial Saude S/A Announces Second Quarter 2008 Earnings Conference Call Webcast
7. The Quantum Group Announces Exclusive Screening of New PWeR(TM) System
8. Burgess Announces Expanded Software Partnership With Health Net
9. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
10. Fast Radios Announces Publication of Two Way Radio Guide for Commercial Customers
11. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...nal healthcare,s uncertain future and rising costs...are. Affordable Acupuncture Scottsdale answers the... 29, 2009 -- Affordable Acupuncture, LLC opened in...en met with enthusiasm and gratitude. Its increasi...to two things, need and cost. "As far as I&r...
(Date:11/28/2009)...d to affect circadian rhythm, , , F...ggests that an internal body clock that goes on th...polar disorder in children. , The finding resu...152 children with bipolar disorder, which can make...children without the disorder. They linked variati...
(Date:11/27/2009)...firm Replikins Ltd. today issued its latest bioche... shows that the lethality of the virus has dropped...s current outbreak in the spring of 2009 to restin... The H1N1 infectivity count, however, remains incr...ovember 27, 2009 -- Biotech firm Replikins Ltd., w...
(Date:11/27/2009)...rance, Nov. 27 Team Garmin-Slipstr...dedicated to ethical sporting and developing the n...ay that it will become Team Garmin-Transitions wit...nsor of the team. Transitions Optical is the world...ing the most advanced photochromic technology in t...
(Date:11/27/2009)...ed medical, economic burdens, study predicts , ...umber of people with diabetes in the United States...ew study predicts. , That would bring the total...ease, up from 23.7 million today. , , At the sam...will triple, the study also warns, rising from an ...
Breaking Medicine News(10 mins):Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... that tight glucose control can lower the risk of ...ype 1. Keeping a tight glucose control on the...abetes is to keep their blood sugar as close to th...adjusting medication according to the daily food i...
...n D and calcium can ward off an attack of premenst... (PMS) is the set of symptoms that affect a lot of... Some common symptoms of PMS are depression, feeli...ted because of their physical conditions. Res...
...und the occurrence diabetic retinopathy in a numbe...betes type 2. Diabetes type 2 happens when bo...ar. As this happens the body becomes unable to pro...ood glucose existent in patients, but the levels a...
...n, researchers have shown that twisting the graft ...rk better and last longer. In using a graft t...rosthetic tubes. Similar tubes are also used when ... blood flows twisting and turning as the artery go...
...en able to generate human skin tissues, which have.... The researchers for the study feel that this wil...otential of genes in development of skin cancer. ...ord University School of Medicine have introduced ...
... people with low birth weight may help themselves ...iet and controlling their body weights. Diabe...he metabolism of blood glucose and impaired functi...ence and age related factors. Recent studies have ...
Other Medicine News:
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc. is pleased to ...l DR cassette, at the 2009 Radiological Society of...ny clinical environment, FDR D-EVO uses an innovat...film,s trademark image quality and outstanding fle...o transition to DR without modification to the exa...
(Date:11/29/2009)... Researchers using functional magnetic resonance i... that men and women respond differently to positiv...nted today at the annual meeting of the Radiologic... direct more attention to sensory aspects of emoti...implications for required action, whereas women di...
(Date:11/27/2009)...swire/ -- ACUO TECHNOLOGIES, developers of high-pe...migration tools and services, is pleased to announ...ice has approved a patent application for an "Asse... Acuo Technologies is pleased to add the U.S. pate...eneral, the granted patent application broadly pro...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 1Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 2Treating ROP in tiny preemies 3B better glaucoma follow up in urban clinic 60035 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 1Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 2Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 3Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 4Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 5Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 6Orexigen 28R 29 Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk 60031 7Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 1Gene Therapy Offers Hope for Severe Hereditary Eye Disease 60029 2
...AN FRANCISCO, June 9 Halozyme Therapeutics,Inc. (...oping and,commercializing products targeting the e...ata for the company,s diabetes mellitus program at...ic Sessions. The data,showed that combining the co...e enzyme (rHuPH20) with Humulin R(R) (regular insu...
...SPIRE IRB Is Exhibiting at Bio International Conve... 17-20, Currently, over 54,255 Trials with L... Place, SAN DIEGO, June 9 ASPI...nt Review Board (IRB), is,responsible for overseei...of people participating in clinical trials. ASPIRE...
Other Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 2ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 3
...e of miniTHERM incubators is available, ensuring t...olution for their specific requirements. miniTHERM...act and extremely space saving. Their size corresp... is possible to stack up to three units on top of ...
...e of miniTHERM incubators is available, ensuring t...olution for their specific requirements. miniTHERM...act and extremely space saving. Their size corresp... is possible to stack up to three units on top of ...
Heraeus CO2 Incubator BBD 6220
Steri-Cult CO2 Incubators
Medicine Products: